# Baseimmune

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/baseimmune

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.baseimmune.co.uk
- Total disclosed funding: $16M
- Latest round: Series A (Jan 5, 2024)
- Investors on record: 8

## About

Based in London, UK, and founded in 2019 by CEO Joshua Blight, CSO Ariane C. Gomes, and CTO Phillip Kemlo, Baseimmune Ltd., a.k.a. Baseimmune, operates as a biotechnology company that leverages a proprietary AI-platform to design vaccines capable of withstanding pathogen mutations. In January 2024, Baseimmune Ltd. raised GBP 9 million in a Series A funding co-led by Merck Global Health Innovation Fund and IQ Capital, with participation from Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc. The series A round of financing values Baseimmune Ltd. at GBP 37.67 million post-money. 

Baseimmune's discovery platform integrates genomic, proteomic, epidemiological, and immunological data to generate multi-target antigens and validate vaccine candidates. The company’s early-stage pipeline includes vaccines for malaria, coronaviruses, and African swine fever, employing advanced mRNA/LNP and viral vector technologies.

The company plans to use its proceeds from January 2024 funding to further develop its technology, grow its workforce, accelerate the development of new vaccine programs, and advance its three vaccine candidates.

## Funding rounds

- Series A, Jan 5, 2024, $11M — Merck Global Health Innovation Fund, IQ Capital, Hoxton Ventures, Beast Ventures, Maki.vc, Creator Fund
- Seed, Sep 15, 2021, $4.8M — Hoxton Ventures, Cherry Ventures, Beast Ventures, Maki.vc, Creator Fund, Rockmount Seed Investments

## Investors

- Hoxton Ventures (https://capitalatlas.ai/funds/hoxton-ventures) — Seed, Series A
- Cherry Ventures (https://capitalatlas.ai/funds/cherry-ventures) — Seed
- Beast Ventures (https://capitalatlas.ai/funds/beast-ventures) — Seed, Series A
- Maki.vc (https://capitalatlas.ai/funds/maki-vc) — Seed, Series A
- Creator Fund (https://capitalatlas.ai/funds/creator-fund) — Seed, Series A
- Rockmount Seed Investments (https://capitalatlas.ai/funds/rockmount-seed-investments) — Seed
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series A
- IQ Capital (https://capitalatlas.ai/funds/iq-capital) — Series A